TEVA CANADA LIMITED v. NOVARTIS PHARMACEUTICALS CANADA INC ET. AL.
Summary of A-404-15
The following information was obtained from the Federal Court or Federal Court of Appeal websites but is NOT the official version. See links below for the court websites.
Federal Court Type: Appeal (S.27 - Final) - Patent Act
Parties and Lawyers:| Party | Firm | Lawyer |
|---|---|---|
| NOVARTIS AG | ||
| NOVARTIS PHARMACEUTICALS CANADA INC | ||
| TEVA CANADA LTD | AITKEN KLEE LLP | AITKEN, DAVID W |
| THE MINISTER OF HEALTH |
| Name | Number |
|---|---|
| 2255951 |
Decisions
| Name | Date | Paragraph |
| Teva Canada Limited v. Novartis Pharmaceuticals Canada Inc. 2016 FCA 230 | Sep 15, 2016 | For reasons cited as 2015 FC 770 the Federal Court issued a judgment prohibiting the Minister of Health from issuing a Notice of Compliance to Teva Canada Limited in respect of a generic version of Novartis Pharmaceuticals Canada Inc.’s patented product EXJADE. The Federal Court concluded that Teva’s allegations of inutility, obviousness and insufficiency were not justified. On this appeal from the judgment of the Federal Court, Teva only places in issue the conclusion of the Federal Court that Teva’s allegation of inutility was not justified. In my view, and Teva agrees, this appeal turns on a single issue: did the Federal Court err in law in its construction of the promise of the relevant patent? ... As the Federal Court found, this patent can be read by a person skilled in the art as excluding Teva’s asserted elevated promise of utility. ... Having construed the stated utility of the patent to be the capacity of the compounds to bind markedly to iron and to be sufficiently soluble to induce iron excretion, the Federal Court went on to conclude that the stated utility had been clearly demonstrated or soundly predicted as of the filing date of the patent (reasons, at paragraph 40). It followed that Teva’s allegation of inutility was not justified. For these reasons, I would dismiss the appeal with costs. |
This is an appeal from 2015 FC 770 in T-1095-13. [Determination of the appeal is based on automated analysis and should not be relied upon.]
Docket Summary (Google Translate to English)
(30) 2019-11-13 - OttawaTraduction certifiée conforme en français du jugement / doc. # 27 rendu(e)(s) le 15-SEP-2016 déposée le 13-NOV-2019 inscrit(e) dans le livre J. & O., volume 309 page(s) 470 - 470
Traduction certifiée conforme en français des motifs du jugement / doc. # 28 rendu(e)(s) le 15-SEP-2016 déposée le 14-SEP-2017
Memorandum to file from the Registry of the FCA dated 16-SEP-2016 transmitting a copy of the Judgment and Reasons to Justice O'Reilly and the Applications section of the FC. placed on file.
Acknowledgment of Receipt received from all parties (email) with respect to the Judgment and Reasons dated September 15, 2016 placed on file on 16-SEP-2016
Reasons for Judgment rendered by The Honourable Madam Justice Dawson concurred in by The Honourable Madam Justice Gauthier The Honourable Mr. Justice Near dated 15-SEP-2016 The Court's decision is with regard to Appeal Filed on 15-SEP-2016
Judgment dated 15-SEP-2016 rendered by The Honourable Madam Justice Dawson The Honourable Madam Justice Gauthier The Honourable Mr. Justice Near Matter considered with personal appearance The Court's decision is with regard to Appeal Result: dismissed Filed on 15-SEP-2016 entered in J. & O. Book, volume 296 page(s) 281 - 281 (Final decision)
This matter comes on for hearing on 07-SEP-2016 at Ottawa before The Honourable Madam Justice Dawson The Honourable Madam Justice Gauthier The Honourable Mr. Justice Near Appearances: Mr. Jonathan Stainsby and Mr. Scott Beeser 613-903-5099 for the appellant Mr. Anthony Creber and Mr. Alex Gloor 613-233-1781 for Novartis Pharmaceuticals Canada Inc. and Novartis AG Language of Hearing: E Court Usher: Pierre Gendron Duration: on 07-SEP-2016 from 09:30 to 03:15 Courtroom : Federal Court of Appeal Courtroom - Ottawa Court Registrar Jean-François Duport Total duration: 5 hours 45 minutes Before the Court: appeal Result: reserved Comments: Supplemental authorities and compendium received at hearing. Minister of Health did not participate. Minutes of Hearing entered in Vol. 219 page(s) 301 - 308 Abstract of Hearing placed on file
Covering letter from Novartis dated 26-AUG-2016 concerning Doc. Nos. 25 26 placed on file on 29-AUG-2016
Solicitor's certificate of service on behalf of Alex Gloor confirming service of doc. 25 upon all parties by courier on 26-AUG-2016 filed on 29-AUG-2016
Supplemental Authorities consisting of 1 volume(s) on behalf of Novartis Pharmaceuticals Canada Inc. and Novartis AG Filed on 29-AUG-2016 3 copy(ies) for the Court stored in Ottawa
Oral directions of the presiding judge dated 29-AUG-2016 directing that the Supplemental Authorities of Novartis Pharmaceuticals Canada Inc. and Novartis AG may be accepted for filing. received on 29-AUG-2016
Covering letter from the Respondent, Novartis dated 23-AUG-2016 concerning Doc. Nos. 23 24 placed on file on 23-AUG-2016
CD containing Novartis' Memorandum of Fact and Law placed on file on 23-AUG-2016
Solicitor's certificate of service on behalf of Alex Gloor confirming service of Doc. No. 23 upon all parties by personal service on 23-AUG-2016 filed on 23-AUG-2016
Compendium of the Respondent , Novartis Pharma Canada filed on 23-AUG-2016
Covering letter from Appellant dated 03-AUG-2016 concerning Doc. Nos. 21 22 placed on file on 03-AUG-2016
Solicitor's certificate of service on behalf of Scott A. Beeser confirming service of Joint Book of Authorities upon Respondents by personal service on 03-AUG-2016 filed on 03-AUG-2016
Joint Book of Authorities consisting of 4 volume(s) on behalf of Appellant Filed on 03-AUG-2016 3 copy(ies) for the Court stored in Ottawa
Transmission of the hearing date order: to Mr. Beeser, for the Appellant (by e-mail, receipt acknowledged), to Mr. Creber, for Novartis (by fax, successful transmission) and to Mr. Peterson, for the Minister of Health (by e-mail, receipt acknowledged) placed on file on 02-JUN-2016
Order (time and place) dated 27-MAY-2016 rendered by S. Bazinet, Judicial Administrator and signed by Judicial Administrator fixing Appeal to be heard at Special Sitting in Ottawa on 07-SEP-2016 to begin at 09:30 Filed on 27-MAY-2016 cc's sent to parties entered in J. & O. Book, volume 295 page(s) 75 - 75 Transmittal letters placed on file
Covering letter from Respondent dated 11-APR-2016 concerning CD containing the Memorandum of Fact and Law of the Respodents, Novartis Pharmaceuticals Canada Inc. and Novartis AG placed on file on 11-APR-2016
Letter from the appellant dated 08-APR-2016 enclosing CD containing the Pdf format of Judgment and Reasons of Justice O'Reilly and other documents. received on 08-APR-2016
Communication from Registry to Judicial Administrator dated 01-APR-2016 re: fixing the date, time, and place for the hearing.
Solicitor's certificate of service on behalf of Appellant confirming service of doc.18 upon Respondent by telecopier on 29-MAR-2016 filed on 29-MAR-2016
Requisition for hearing - Appeal from Appellant filed on 29-MAR-2016
Affidavit of Nancy Gallinger on behalf of the Respondent (Novartis Pharmaceuticals Canada INc., and Novartis AG) sworn on 07-MAR-2016 confirming service of Doc. No. 16 on the Appellant and the Respondent (Minister of Health) by courier on 07-MAR-2016 filed on 07-MAR-2016
Memorandum of fact and law on behalf of the Respondent (Novartis Pharmaceuticals Canada Inc., Novartis AG) filed on 07-MAR-2016 3 judges' copies stored in Ottawa
Covering letter from Appellant dated 20-JAN-2016 concerning Doc. Nos. 13 14 15 placed on file on 20-JAN-2016
Solicitor's certificate of service on behalf of Scott A. Beeser confirming service of doc. No. 14 upon Respondent by personal service on 20-JAN-2016 filed on 20-JAN-2016
Memorandum of fact and law on behalf of the appellant filed on 20-JAN-2016
Consent to an extension of time to January 20, 2016 for the serving and filing of the A's Memorandum of Fact and Law and to March 7, 2016 for the serving and filing of the R's Memorandum of Fact and Law on behalf of all parties filed on 20-JAN-2016
Solicitor's certificate of service on behalf of Scott A. Beeser confirming service of Doc 11 upon Respondents by courier on 17-NOV-2015 filed on 18-NOV-2015
Appeal Book consisting of 17 volume(s) prepared by the appellant filed on 18-NOV-2015 3 judges' copies stored in Ottawa
Covering letter from Appellant dated 19-OCT-2015 concerning Doc. Nos. 9 10 placed on file on 19-OCT-2015
Solicitor's certificate of service on behalf of Scott A. Beeser confirming service of Agreement to contents of Appeal Book doc.09 upon Respondents by telecopier on 19-OCT-2015 filed on 19-OCT-2015
Agreement as to the content of the Appeal book from both partie filed on 19-OCT-2015
Covering letter from Respondent, the Ministry of Health, dated 24-SEP-2015 concerning Doc. Nos. 7 8 placed on file on 24-SEP-2015
Affidavit of James Adeney on behalf of Respondent, the Ministry of Health, sworn on 24-SEP-2015 confirming service of Doc. 7 on the appellant and Respondents, Novartis Pharmaceuticals Canada Inc. and Novartis AG, by telecopier on 24-SEP-2015 with attached exhibit(s) A filed on 24-SEP-2015
Notice of appearance on behalf of Respondent, the Minister of Health, filed on 24-SEP-2015
Affidavit of Nancy Gallinger on behalf of the appellant sworn on 22-SEP-2015 confirming service of Notice of Appearance doc. no. 5 on all Respondents by telecopier on 22-SEP-2015 filed on 23-SEP-2015
Notice of appearance on behalf of all Respondents filed on 23-SEP-2015
Solicitor's certificate of service on behalf of Jeffrey Warnock confirming service of doc. 1 upon Novartis respondents by telecopier on 18-SEP-2015 filed on 18-SEP-2015
Copy of Doc#1 Notice of Appeal with proof of service on Respondents, Novartis Pharmaceuticals Canada Inc. and Novartis AG on 18-SEP-2015 filed on 18-SEP-2015
Memorandum to file from the FCA Registry dated 21-SEP-2015 transmitting a copy of the Notice of Appeal to the Honourable Justice O'Reilly and to the Applications section of the FC. placed on file.
Copy of Notice of Appeal doc. no. 1 with proof of service on the respondent on 21-SEP-2015 filed on 21-SEP-2015
Notice of Appeal and 2 copies filed on 17-SEP-2015 against a decision Reasons for Judgment and Judgment of Justice O'Reilly dated June 19, 2015 in Court File no. T-1095-13. Certified copy(ies)/copy(ies) transmitted to Deputy Attorney General of Canada Tariff fee of $50.00 received: yes
The official version of the court proceeding information is available from the court websites directly: